Ven Bio Partners LLC Verona Pharma PLC Transaction History

Ven Bio Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$7.08 - $9.33 $263,220 - $346,870	-37,178 Reduced 18.68%	161,897 $1.35 Million
Q3 2020 Nov 16, 2020	SELL	$4.45 - $10.2 $1.15 Million - $2.63 Million	-257,695 Reduced 56.42%	199,075 $1.24 Million
Q1 2020 May 15, 2020	SELL	$2.16 - $7.28 $903,376 - $3.04 Million	-418,230 Reduced 47.8%	456,770 $1.88 Million
Q4 2018 May 26, 2020	BUY	$9.0 - $13.47 $7.88 Million - $11.8 Million	875,000 New	875,000 $8.44 Million

225

67.7M

1.4M

299K

Ticker VRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,954,200
Market Cap $3.52B
Description
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...

Get notified when there are updates to the investment portfolio of Ven Bio Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Ven Bio Partners LLC with notifications on news.